Skip to main content

Cecile Guegan

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

Get PFE alerts

About Cecile Guegan

Cecile Guegan is recorded as CFO at Pfizer Inc (PFE) since August 16, 2026. Pfizer Inc reported in an 8-K filed November 3, 2026 that Cecile Guegan was appointed Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026. Pfizer Inc reported in an 8-K filed June 18, 2026 that Cecile Guegan was appointed Interim Chief Financial Officer, effective August 16, 2026. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), D. Denton (CFO) and 6 others.

“On November 3, 2026, Pfizer Inc. (the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”).”
Pfizer Inc Form 8-K, filed November 3, 2026 · Read the filing
“the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026, while the Company conducts a comprehensive process to identify Mr. Denton’s successor.”
Pfizer Inc Form 8-K, filed June 18, 2026 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - General · Healthcare

CFO

2026-08-16–present

Leadership on record at Pfizer Inc

Recent activity